Ralph Dr. Kern Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

BCLI Quotes by TradingView

Ralph Dr. Kern is COO and Chief Medical Officer of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 223,310 shares of BCLI, which is worth approximately $361,762. The most recent transaction as insider was on Mar 06, 2022, when has been sold 35,885 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 223K
0% 3M change
0% 12M change
Total Value Held $361,762

Ralph Dr. Kern Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2022
BUY
Grant, award, or other acquisition
-
35,885 Added 13.84%
223,310 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
-
35,885 Added 16.07%
187,425 Common Stock
RDK

Ralph Dr. Kern

COO and Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCLI